Compared to Estimates, DexCom (DXCM) Q1 Earnings: A Look at Key Metrics

Core Insights - DexCom reported $1.04 billion in revenue for Q1 2025, marking a year-over-year increase of 12.5% and a surprise of +1.99% over the Zacks Consensus Estimate of $1.02 billion [1] - The EPS for the same period was $0.32, unchanged from the previous year, with a slight miss of -3.03% against the consensus estimate of $0.33 [1] Revenue Breakdown - International revenue was $285.50 million, below the average estimate of $303.93 million, reflecting a year-over-year increase of +6.6% [4] - U.S. revenue reached $750.50 million, exceeding the average estimate of $709.42 million, with a year-over-year growth of +14.9% [4] - Hardware revenue was reported at $38.80 million, slightly above the two-analyst average estimate of $38.39 million, but showed a significant year-over-year decline of -41.8% [4] - Revenue from sensors and other products was $997.20 million, surpassing the two-analyst average estimate of $978.78 million, with a year-over-year increase of +16.7% [4] Stock Performance - DexCom shares have returned +4.8% over the past month, contrasting with a -0.7% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]